{"denomUnitsSelected":"Participants","description":"A patient who has SBRT planned for at least one metastatic site and receives successful SBRT treatment to at least 85% of metastatic sites in the treatment plan. Successful treatment is determined by IROC review criteria. Only eligible patients start the metastatic site radiation reporting period will be considered for this outcome measure.","reportingStatus":"NOT_POSTED","timeFrame":"202 days","title":"Proportion of Patients Who Successfully Receive Planned Stereotactic Body Radiotherapy (SBRT)","type":"OTHER_PRE_SPECIFIED"}